Audit 322450

FY End
2023-12-31
Total Expended
$323.52M
Findings
0
Programs
40
Organization: Albany Medical Center (NY)
Year: 2023 Accepted: 2024-09-30
Auditor: Kpmg LLP

Organization Exclusion Status:

Checking exclusion status...

Findings

No findings recorded

Programs

ALN Program Spent Major Findings
14.128 Mortgage Insurance_hospitals $59.07M Yes 0
84.268 Federal Direct Student Loans $28.50M Yes 0
93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders $1.48M - 0
93.859 Biomedical Research and Research Training $1.44M - 0
93.918 Grants to Provide Outpatient Early Intervention Services with Respect to Hiv Disease $1.02M - 0
12.420 Military Medical Research and Development $816,730 - 0
93.153 Coordinated Services and Access to Research for Women, Infants, Children, and Youth $774,979 - 0
93.846 Arthritis, Musculoskeletal and Skin Diseases Research $722,978 - 0
93.342 Health Professions Student Loans, Including Primary Care Loans/loans for Disadvantaged Students $703,369 Yes 0
84.038 Federal Perkins Loan Program $698,734 Yes 0
93.498 Covid-19 Provider Relief Fund $600,833 - 0
97.036 Covid-19 Disaster Grants - Public Assistance (presidentially Declared Disasters) $333,726 - 0
93.279 Drug Abuse and Addiction Research Programs $331,453 - 0
10.561 Creating Healthy Schools and Communities $310,846 - 0
84.033 Federal Work-Study Program $185,224 Yes 0
93.917 Hiv Care Formula Grants $169,936 - 0
93.394 Cancer Detection and Diagnosis Research $165,801 - 0
10.557 Special Supplemental Nutrition Program for Women, Infants, and Children $119,474 Yes 0
93.145 Aids Education and Training Centers $92,879 - 0
93.865 Child Health and Human Development Extramural Research $88,206 - 0
32.005 Universal Service Fund - Rural Health Care $80,328 - 0
93.838 Lung Diseases Research $74,277 - 0
93.233 National Center on Sleep Disorders Research $72,863 - 0
93.788 Opioid Str $51,027 - 0
10.558 Child and Adult Care Food Program $49,170 - 0
20.616 National Priority Safety Programs $42,937 - 0
93.839 Blood Diseases and Resources Research $39,169 - 0
16.588 Violence Against Women Formula Grants $38,868 - 0
93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research $38,015 - 0
93.889 National Bioterrorism Hospital Preparedness Program $32,000 - 0
93.242 Mental Health Research Grants $22,047 - 0
93.172 Human Genome Research $21,644 - 0
93.110 Maternal and Child Health Federal Consolidated Programs $19,250 - 0
93.837 Cardiovascular Diseases Research $18,639 - 0
93.396 Cancer Biology Research $14,556 - 0
93.395 Cancer Treatment Research $12,078 - 0
93.286 Discovery and Applied Research for Technological Innovations to Improve Human Health $10,670 - 0
93.855 Allergy, Immunology and Transplantation Research $7,100 - 0
93.074 Hospital Preparedness Program (hpp) and Public Health Emergency Preparedness (phep) Aligned Cooperative Agreements $4,287 - 0
93.866 Aging Research $-5,871 - 0

Contacts

Name Title Type
XTR3TL3BC9D3 Annmarie McIntosh Auditee
5182622202 Jayme M Silva Auditor
No contacts on file

Notes to SEFA

Title: (1)    Basis of Presentation Accounting Policies: Expenditures reported on the Schedule are reported on the accrual basis of accounting. Expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. Negative amounts shown on the Schedule, if any, represent adjustments or credits made in the normal course of business to amounts reported as expenditures in prior years. De Minimis Rate Used: N Rate Explanation: We used the rate outlined in our rate agreement and as indicated on the award. The accompanying schedule of expenditures of federal awards (the Schedule) includes the federal award activity of Albany Med Health System (the System) under programs of the federal government for the year ended December 31, 2023, as applicable, except for Kaaterskill Commons, Inc., which is subject to a separate audit in compliance with the Uniform Guidance. The information in the Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulation, Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Because the Schedule presents only a select portion of the operations of the System, it is not intended to and does not present the financial position, changes in net assets, or cash flows of the System.
Title: (2)    Summary of Significant Accounting Policies Accounting Policies: Expenditures reported on the Schedule are reported on the accrual basis of accounting. Expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. Negative amounts shown on the Schedule, if any, represent adjustments or credits made in the normal course of business to amounts reported as expenditures in prior years. De Minimis Rate Used: N Rate Explanation: We used the rate outlined in our rate agreement and as indicated on the award. Expenditures reported on the Schedule are reported on the accrual basis of accounting. Expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. Negative amounts shown on the Schedule, if any, represent adjustments or credits made in the normal course of business to amounts reported as expenditures in prior years. The System has elected not to use the 10‑percent de minimis indirect cost rate allowed under the Uniform Guidance. Indirect costs are charged to federal grants and contracts at a federally approved predetermined rate. The predetermined rates for the year ended December 31, 2023 were 63% and 26% for on‑campus programs and off‑campus programs, respectively. Indirect costs are included in the reported federal expenditures.
Title: (3)    Federal Student Loan and Loan Guarantee Programs Accounting Policies: Expenditures reported on the Schedule are reported on the accrual basis of accounting. Expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. Negative amounts shown on the Schedule, if any, represent adjustments or credits made in the normal course of business to amounts reported as expenditures in prior years. De Minimis Rate Used: N Rate Explanation: We used the rate outlined in our rate agreement and as indicated on the award. (A) Federal Student loan programs The federal student loan programs listed below are administered directly by the System, and balances and transactions relating to these programs are included in the System’s combined financial statements. Loans outstanding at the beginning of the year and loans made during the year are included in the federal expenditures presented in the Schedule. No federally reimbursed administrative costs were incurred by the College. (1) Federal Perkins Loan Program For the years ended December 31, 2023 and 2022, the College made no loans under the Federal Perkins Loan Program (Assistance Listing Number (ALN) 84.038). The outstanding balance of loans under the Federal Perkins Loan Program was $430,692 at December 31, 2023. (2) Health Professions Student and Primary Care Loan Program For the year ended December 31, 2023, the College made no new loans under the Health Professions Student and Primary Care Loan Programs (ALN 93.342). The outstanding balance of loans under the Health Professions Student and Primary Care Loan Programs was $773,263 at December 31, 2023. (3) Loans for Disadvantaged Students Program For the year ended December 31, 2023, the College made no new loans under the Loans for Disadvantaged Students Program (ALN 93.342). The outstanding balance of loans under the Loans for Disadvantaged Students Program was $683,860 at December 31, 2023. (b) Federal Student Loan Guarentee Program The College offers student financial assistance through the Federal Direct Student Loan Program under a program with the U.S. Department of Education (ALN 84.268), which is a student loan guarantee program. The College is only responsible for the performance of certain administrative duties relating to this program. The loans processed and guaranteed under this program during the year ended December 31, 2023 and included in the federal expenditures presented in the Schedule were $28,496,163.
Title: (4)    Mortgage Insurance Guarantee Program Accounting Policies: Expenditures reported on the Schedule are reported on the accrual basis of accounting. Expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. Negative amounts shown on the Schedule, if any, represent adjustments or credits made in the normal course of business to amounts reported as expenditures in prior years. De Minimis Rate Used: N Rate Explanation: We used the rate outlined in our rate agreement and as indicated on the award. Albany Medical Center Hospital (AMCH) has the following long‑term debt obligations outstanding as of December 31, 2023 which are insured against loss on mortgages to the lenders by the U.S. Department of Housing and Urban Development: In April 2017, AMCH closed on a $65,000,000 FHA insured construction loan (2017 Mortgage Loan) to finance the costs to construct a new Pediatric Emergency Department building and complete other renovations within the AMCH complex to increase patient care capacity. The 2017 Mortgage Loan is insured under the FHA 241 Program, with Prudential Huntoon Paige as the lender. It is secured by a lien on substantially all of AMCH’s property, equipment, and gross receipts. The loan has a fixed interest rate of 4.26%, had an interest only 23 month construction period. Principal payments commenced in April 2019 based on a 25 year schedule and the loan matures on March 1, 2044. Construction began in the spring of 2017 and was completed mid 2020. In December 2010, AMCH closed on a $321,440,200 Mortgage Loan (2010 Mortgage Loan) which was comprised of a “Refinance Loan” of $9,584,200 and a “Patient Tower” Loan of $311,856,000 (which was reduced by $50,220,000 to $261,636,000 at Final Endorsement). The 2010 Mortgage Loan is insured under the FHA 241 program, with Prudential Huntoon Paige Associates as the lender. The 2010 Mortgage Loan is currently secured by a first lien mortgage on substantially all of AMCH’s property, equipment, and gross receipts, and a first mortgage lien on the South Clinical Campus of AMCH. The Refinance Loan was used to retire the Series 1999 Bonds, the original purpose of which was to acquire properties and rights of the former Child’s Hospital and Samaritan Service Corporation. The interest rate is 4.66% on the Refinance Loan and is payable through May 1, 2029. The Patient Tower Loan was used to finance AMCH’s expansion project consisting of a six story patient tower, which contains 96 new beds, 20 new operating rooms and a co generation plant. Final endorsement occurred in September 2014 in the amount of $261,636,055. The Patient Tower Loan has an interest rate of 6.2% and a maturity date of July 2038. Loan balances outstanding at the beginning of the year plus new loans made during the year are included in the federal expenditures presented in the Schedule.
Title: (5)    Noncash Assistance Accounting Policies: Expenditures reported on the Schedule are reported on the accrual basis of accounting. Expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. Negative amounts shown on the Schedule, if any, represent adjustments or credits made in the normal course of business to amounts reported as expenditures in prior years. De Minimis Rate Used: N Rate Explanation: We used the rate outlined in our rate agreement and as indicated on the award. Included in the Special Supplemental Nutrition Program for Women, Infants, and Children expenditures (ALN 10.557) is $1,941,197 of noncash assistance, which is the value of checks redeemed and electronic benefits transfers payments to beneficiary enrolled in the federal program by the System during the fiscal year.